Johnson & Johnson said it will work with the Rega Institute for Medical Research in Belgium to identify antiviral, therapeutic candidates to treat the disease caused by the novel coronavirus, in an expanded effort with the Department of Health and Human Services.
Continue Reading Below
Janssen Pharmaceutical Cos., a J&J company, and the department's Biomedical Advanced Research and Development Authority will share costs in discovering the treatment, the company said Tuesday.
J&J last week said it will work with HHS to accelerate the development of a potential coronavirus vaccine.
J&J shares rose 0.2 percent.